Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07042113 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China

Name: A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China — clinical trial record (NCT07042113)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: 611

StatusNot Yet Recruiting

PhasePhase 1

SponsorSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Started2025-07

View on ClinicalTrials.gov ↗

Record status

This record was last updated June 27, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

22 trials monitored

See all monitored trials

Atopic Dermatitis

489 trials monitored

See 14 trials at risk

The main purpose of this study is to compare two different formulations (mixtures) of 611 in healthy participants. This study will compare how much of each formulation gets into the blood stream.

Trial Details

NCT Number	NCT07042113
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Atopic Dermatitis
Enrollment	180 participants
Start Date	2025-07
Primary Completion	2026-01 (estimated)
Study Completion	2026-01 (estimated)
Updated on ClinicalTrials.gov	2025-06-27